AI Verdict
SKVI has stronger fundamentals based on our AI analysis.
SKVI vs SKYE Fundamental Comparison
| Metric | SKVI | SKYE |
|---|---|---|
| Revenue | $20,000.0 | N/A |
| Net Income | $-1.1M | $-55.9M |
| Net Margin | -5,320.2% | N/A |
| ROE | N/A | -279.3% |
| ROA | -834.1% | -197.5% |
| Current Ratio | 0.01x | 3.30x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.11 | $-1.41 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
SKVI vs SKYE: Frequently Asked Questions
Is SKVI or SKYE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), SKVI has stronger fundamentals. SKVI is rated STRONG SELL (98% confidence) while SKYE is rated STRONG SELL (97% confidence). This is not investment advice.
How does SKVI compare to SKYE fundamentally?
SKINVISIBLE, INC. has ROE of N/A vs Skye Bioscience, Inc.'s -279.3%. Net margins are -5,320.2% vs N/A respectively.
Which stock pays higher dividends, SKVI or SKYE?
SKVI has a dividend yield of N/A or no dividend while SKYE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in SKVI or SKYE for long term?
For long-term investing, consider that SKVI has STRONG SELL rating with 98% confidence, while SKYE has STRONG SELL rating with 97% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about SKVI vs SKYE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For SKVI vs SKYE, the AI consensus favors SKVI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.